Ezogabine treatment shown to reduce motor neuron excitability in ALS patients
Brian Wainger, MD, Ph.D., of the Healey Center for ALS at Massachusetts General Hospital (MGH) presented initial, top-level results of a recently completed phase 2 clinical trial of ezogabine (also called retigabine) on December ...
Dec 10, 2018
0
24